First Human Trial of a Genetically Modified Cancer-Killing Virus

Gut Microbiome May Alter Response to Cancer Therapy - Brigham And Women's Hospital

COVID-19 superspreader events originate from small number of carriers. New study finds 80% of infections occurring at superspreading events arose from only 4% of those who were carrying the virus into the event

Degrading a key cancer cell-surface protein to invigorate immune attack on tumors